Prof. Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute for Diabetes Research, was awarded the 2024 Rachmiel Levine Medal by City of Hope - a prominent biomedical research and treatment institution in the United States, especially recognized for its work in cancer, diabetes, and other life-threatening diseases. The honor recognizes her outstanding contributions to the understanding and prevention of type 1 diabetes.
The award was presented during the Rachmiel Levine-Arthur Riggs Diabetes Research Symposium, hosted at the City of Hope Research Center, USA. As part of the event, Prof. Ziegler delivered an award lecture titled "Determinants of Islet Autoimmunity and Implications for Prevention of Type 1 Diabetes", where she shared key insights from her research on autoimmune processes leading to type 1 diabetes and potential prevention strategies.
Prof. Ziegler is internationally renowned for her pioneering work in diabetes research, particularly in uncovering the early mechanisms of disease development and advancing preventive measures. This award marks a significant recognition of her leadership and dedication to improving the lives of those at risk for diabetes.